129 related articles for article (PubMed ID: 35721046)
1. Impact of Lung Function Decline on Mortality in Lung Transplant Recipients: Long-Term Results From the L-CsA-i Study for the Prevention of Bronchiolitis Obliterans Syndrome.
Kneidinger N; Ghiani A; Milger K; Monforte V; Knoop C; Jaksch P; Parmar J; Ussetti P; Solé A; Müller-Quernheim J; Voelp A; Behr J; Neurohr C
Front Med (Lausanne); 2022; 9():897581. PubMed ID: 35721046
[TBL] [Abstract][Full Text] [Related]
2. Association Between FEV₁ Decline Rate and Mortality in Long-Term Follow-Up of a 21-Patient Pilot Clinical Trial of Inhaled Liposomal Cyclosporine Plus Standard-of-Care Versus Standard-of-Care Alone for Bronchiolitis Obliterans Syndrome After Lung Transplantation.
Iacono A; Wijesinha M; Völp A; Korotun M; Terrin M
Ann Transplant; 2024 May; 29():e942823. PubMed ID: 38741362
[TBL] [Abstract][Full Text] [Related]
3. A randomized controlled trial of liposomal cyclosporine A for inhalation in the prevention of bronchiolitis obliterans syndrome following lung transplantation.
Neurohr C; Kneidinger N; Ghiani A; Monforte V; Knoop C; Jaksch P; Parmar J; Ussetti P; Sole A; Müller-Quernheim J; Kessler R; Wirtz H; Boerner G; Denk O; Prante Fernandes S; Behr J
Am J Transplant; 2022 Jan; 22(1):222-229. PubMed ID: 34587371
[TBL] [Abstract][Full Text] [Related]
4. Bronchiolitis obliterans syndrome-free survival after lung transplantation: An International Society for Heart and Lung Transplantation Thoracic Transplant Registry analysis.
Kulkarni HS; Cherikh WS; Chambers DC; Garcia VC; Hachem RR; Kreisel D; Puri V; Kozower BD; Byers DE; Witt CA; Alexander-Brett J; Aguilar PR; Tague LK; Furuya Y; Patterson GA; Trulock EP; Yusen RD
J Heart Lung Transplant; 2019 Jan; 38(1):5-16. PubMed ID: 30391193
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of early pulmonary function changes after onset of chronic lung allograft dysfunction.
Todd JL; Neely ML; Finlen Copeland CA; Frankel CW; Reynolds JM; Palmer SM
J Heart Lung Transplant; 2019 Feb; 38(2):184-193. PubMed ID: 30466803
[TBL] [Abstract][Full Text] [Related]
6. Early chest CT abnormalities to predict the subsequent occurrence of chronic lung allograft dysfunction.
Habert P; Chetrit E; Coiffard B; Bregeon F; Thomas P; Loundou A; Bermudez J; Reynaud-Gaubert M; Gaubert JY
Insights Imaging; 2023 Sep; 14(1):154. PubMed ID: 37741923
[TBL] [Abstract][Full Text] [Related]
7. Machine Learning Algorithms Utilizing Quantitative CT Features May Predict Eventual Onset of Bronchiolitis Obliterans Syndrome After Lung Transplantation.
Barbosa EJM; Lanclus M; Vos W; Van Holsbeke C; De Backer W; De Backer J; Lee J
Acad Radiol; 2018 Sep; 25(9):1201-1212. PubMed ID: 29472146
[TBL] [Abstract][Full Text] [Related]
8. Montelukast in chronic lung allograft dysfunction after lung transplantation.
Vos R; Eynde RV; Ruttens D; Verleden SE; Vanaudenaerde BM; Dupont LJ; Yserbyt J; Verbeken EK; Neyrinck AP; Van Raemdonck DE; Verleden GM;
J Heart Lung Transplant; 2019 May; 38(5):516-527. PubMed ID: 30638839
[TBL] [Abstract][Full Text] [Related]
9. Bronchiolitis Obliterans Syndrome and Death in Iranian Lung Transplant Recipients: A Bayesian Competing Risks Analysis.
Hosseini-Baharanchi FS; Hajizadeh E; Baghestani AR; Najafizadeh K; Shafaghi S
Tanaffos; 2016; 15(3):141-146. PubMed ID: 28210278
[TBL] [Abstract][Full Text] [Related]
10. A randomised single-centre trial of inhaled liposomal cyclosporine for bronchiolitis obliterans syndrome post-lung transplantation.
Iacono A; Wijesinha M; Rajagopal K; Murdock N; Timofte I; Griffith B; Terrin M
ERJ Open Res; 2019 Oct; 5(4):. PubMed ID: 31687370
[TBL] [Abstract][Full Text] [Related]
11. Total lymphoid irradiation in progressive bronchiolitis obliterans syndrome after lung transplantation: a single-center experience and review of literature.
Lebeer M; Kaes J; Lambrech M; Vanstapel A; Beeckmans H; Ambrocio GPL; Vanaudenaerde BM; Verleden SE; Verbeken EK; Neyrinck AP; Ceulemans LJ; Van Raemdonck DE; Verleden GM; Vos R;
Transpl Int; 2020 Feb; 33(2):216-228. PubMed ID: 31643104
[TBL] [Abstract][Full Text] [Related]
12. Effect of maintenance azithromycin on established bronchiolitis obliterans syndrome in lung transplant patients.
Porhownik NR; Batobara W; Kepron W; Unruh HW; Bshouty Z
Can Respir J; 2008; 15(4):199-202. PubMed ID: 18551201
[TBL] [Abstract][Full Text] [Related]
13. Montelukast for bronchiolitis obliterans syndrome after lung transplantation: A randomized controlled trial.
Ruttens D; Verleden SE; Demeyer H; Van Raemdonck DE; Yserbyt J; Dupont LJ; Vanaudenaerde BM; Vos R; Verleden GM
PLoS One; 2018; 13(4):e0193564. PubMed ID: 29624575
[TBL] [Abstract][Full Text] [Related]
14. Evolution of Functional Exercise Capacity in Lung Transplant Patients With and Without Bronchiolitis Obliterans Syndrome: A Longitudinal Case-Control Study.
Cebrià I Iranzo MÀ; Vos R; Verleden GM; Gosselink R; Langer D
Arch Bronconeumol (Engl Ed); 2019 May; 55(5):239-245. PubMed ID: 30595421
[TBL] [Abstract][Full Text] [Related]
15. Lung Function Trajectory in Bronchiolitis Obliterans Syndrome after Allogeneic Hematopoietic Cell Transplant.
Cheng GS; Storer B; Chien JW; Jagasia M; Hubbard JJ; Burns L; Ho VT; Pidala J; Palmer J; Johnston L; Mayer S; Crothers K; Pusic I; Lee SJ; Williams KM
Ann Am Thorac Soc; 2016 Nov; 13(11):1932-1939. PubMed ID: 27513368
[TBL] [Abstract][Full Text] [Related]
16. Use of CT-SCAN score and volume measures to early identify restrictive allograft syndrome in single lung transplant recipients.
Philippot Q; Debray MP; Bun R; Frija-Masson J; Bunel V; Morer L; Roux A; Picard C; Jebrak G; Dauriat G; Castier Y; Cazes A; Mal H; Taupin JL; Couffignal C; Brugière O
J Heart Lung Transplant; 2020 Feb; 39(2):125-133. PubMed ID: 31836403
[TBL] [Abstract][Full Text] [Related]
17. Impact of Forced Expiratory Volume in 1 Second (FEV1) and 6-Minute Walking Distance at 3, 6, and 12 Months and Annually on Survival and Occurrence of Bronchiolitis Obliterans Syndrome (BOS) After Lung Transplantation.
Fakhro M; Ingemansson R; Algotsson L; Lindstedt S
Ann Transplant; 2017 Sep; 22():532-540. PubMed ID: 28871078
[TBL] [Abstract][Full Text] [Related]
18. Disease progression in patients with the restrictive and mixed phenotype of Chronic Lung Allograft dysfunction-A retrospective analysis in five European centers to assess the feasibility of a therapeutic trial.
Gottlieb J; Verleden GM; Perchl M; Valtin C; Vallee A; Brugière O; Bravo C
PLoS One; 2021; 16(12):e0260881. PubMed ID: 34941934
[TBL] [Abstract][Full Text] [Related]
19. Incidence, management and outcome of respiratory syncytial virus infection in adult lung transplant recipients: a 9-year retrospective multicentre study.
Testaert H; Bouet M; Valour F; Gigandon A; Lafon ME; Philit F; Sénéchal A; Casalegno JS; Blanchard E; Le Pavec J; Ader F
Clin Microbiol Infect; 2021 Jun; 27(6):897-903. PubMed ID: 32827713
[TBL] [Abstract][Full Text] [Related]
20. Anti-inflammatory and immunomodulatory properties of azithromycin involved in treatment and prevention of chronic lung allograft rejection.
Vos R; Vanaudenaerde BM; Verleden SE; Ruttens D; Vaneylen A; Van Raemdonck DE; Dupont LJ; Verleden GM
Transplantation; 2012 Jul; 94(2):101-9. PubMed ID: 22461039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
